Takefumi Suzuki

Pharmacokinetics of antipsychotics are generally slower centrally than peripherally. This review examined the possible dissociation between central D2 receptor occupancy with antipsychotics and their peripheral blood concentrations.

Since older patients are known to be hypersensitive to antipsychotics, are they vulnerable to developing hyperprolactinemia with these drugs? This post hoc study looked at whether the dopamine D2/3...

When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out...

 

 

Poor treatment adherence masks the true extent of placebo effects in trials of antipsychotics in schizophrenia. Can use of an injectable placebo in double-blind trials of long-acting injectable antipsychotics...

Placebo effects are a common obstacle in the search for Alzheimer's disease treatments. This analysis of data from the large CATIE-AD study investigates ways to screen out potential placebo...

A key to improving prognosis in bipolar depression may lie in analysis of specific symptoms. This reanalysis of the STEP-BD dataset provides clues to help you determine which patients...

 

 

Single-daily-dose regimens are easier for patients to follow than multiple-dose regimens and may increase adherence. But do they work as well? And are they safe? Read this meta-analysis to...

This study compared proportions of patients with comorbid psychiatric disorders among those hospitalized for either pulmonary embolism, a common cause of sudden cardiac arrest in psychiatric patients, or acute...